Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million

Key points:

·Income Decline: In the 2025 fiscal year, Ispire Technology's operating income was $127.5 million, a 16.1% decrease from the $151.9 million in the 2024 fiscal year. 

·Gross profit and gross margin decrease: Gross profit decreased from $29.8 million to $22.6 million, with the gross margin decreasing from 19.6% to 17.8%. 

·Net loss expands: The net loss expanded from $14.8 million to $39.2 million. 

·Strategic transformation: The company continues to transition from the cannabis industry to the nicotine sector.

On September 17, 2025 - According to a report on the Ispire Technology website on September 16, Ispire Technology Inc. (NASDAQ: ISPR) announced its fiscal year financial report for the period ending on June 30, 2025. The report showed that the company's revenue for the 2025 fiscal year was $127.5 million, a decrease from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million in the previous fiscal year to $22.6 million, with a gross profit margin dropping from 19.6% to 17.8%. Net losses widened from $14.8 million in the previous fiscal year to $39.2 million. As of June 30, 2025, the company held cash and cash equivalents of $24.4 million, with operating capital of $400,000.

In the 2025 fiscal year, Ispire's revenue was $127.5 million, a decrease from $151.9 million in the 2024 fiscal year. This decline is primarily due to the company's strategic repositioning from the cannabis sector to the nicotine sector, despite the aim of achieving more sustainable long-term growth through this transition. Gross profit decreased from $29.8 million in the previous fiscal year to $22.6 million, with a gross margin drop from 19.6% to 17.8%. Total operating expenses increased from $43.7 million in 2024 to $60.5 million, mainly due to higher sales and marketing expenses and an increase in expected credit losses on accounts receivable.

The net loss expanded from $14.8 million in the 2024 fiscal year to $39.2 million in the 2025 fiscal year. This increase in loss reflects the challenges the company is facing during its strategic transformation, including increased operational expenses and declining revenues. As of June 30, 2025, the company held $24.4 million in cash and cash equivalents, with operating capital of $400,000.

Ispire Co-CEO Michael Wang said, "The 2025 fiscal year is a crucial period for Ispire's strategic transformation as we continue to shift our focus from the cannabis industry to the higher value nicotine industry. We have made sound strategic decisions, prioritizing quality customers over quantity, and repositioning our business for sustainable growth while prioritizing long-term partnerships. Our investments in groundbreaking technologies, including IKE Tech LLC and G-Mesh technology, are gaining favor with major tobacco companies as these innovative technologies go through regulatory approval processes.